Literature DB >> 11816798

Alzheimer's disease: my point of view.

I Gozes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11816798     DOI： 10.1385/jmn:17:2:269

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN： 0895-8696            Impact factor:   3.444


× No keyword cloud information.
  18 in total

Review 1.  Neuroprotective peptide drug delivery and development: potential new therapeutics.

Authors:  I Gozes
Journal:  Trends Neurosci       Date:  2001-12       Impact factor: 13.837

2.  Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal.

Authors:  S Aronov; G Aranda; L Behar; I Ginzburg
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency.

Authors:  A Bowirrat; R P Friedland; J Chapman; A D Korczyn
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

Review 4.  Genetic factors in Alzheimer's disease: a review of recent advances.

Authors:  E Levy-Lahad; T D Bird
Journal:  Ann Neurol       Date:  1996-12       Impact factor: 10.422

Review 5.  A new concept in the pharmacology of neuroprotection.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

6.  Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

Authors:  D Offen; Y Sherki; E Melamed; M Fridkin; D E Brenneman; I Gozes
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

7.  Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

Authors:  Y Chen; L Lomnitski; D M Michaelson; E Shohami
Journal:  Neuroscience       Date:  1997-10       Impact factor: 3.590

8.  A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.

Authors:  L Beni-Adani; I Gozes; Y Cohen; Y Assaf; R A Steingart; D E Brenneman; O Eizenberg; V Trembolver; E Shohami
Journal:  J Pharmacol Exp Ther       Date:  2001-01       Impact factor: 4.030

9.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 10.  Acetylcholinesterase--new roles for an old actor.

Authors:  H Soreq; S Seidman
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870
View more
  1 in total

1.  The Future for Dementia Research: a Perspective from the Journal of Molecular Neuroscience.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-11       Impact factor: 3.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.